What question did this study set out to answer?

The study aims to understand how IRF1 influences B-cell differentiation in autoimmune conditions, specifically systemic lupus erythematosus.

IRF1 tunes the IRF4—IRF8 axis to drive effector B-cell fates in autoimmunity and inflammaging 2258675

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial shows IRF1 modulates B-cell differentiation in systemic lupus erythematosus, suggesting new therapeutic targets.

The study aims to understand how IRF1 influences B-cell differentiation in autoimmune conditions, specifically systemic lupus erythematosus.
Human SLE and healthy donor B cells were compared for IRF1 mRNA levels and chromatin accessibility.
IRF1 expression was enforced in B cells to evaluate effects on effector gene expression and differentiation.
Irf1 deletion was performed in mouse models to assess changes in B-cell populations and related renal pathology.
Human SLE B cells exhibited higher IRF1 mRNA levels compared to healthy B cells.
Irf1 deletion led to reduced antibody-secreting cell production and improved kidney health in lupus-prone mice.
Loss of IRF1 altered B-cell differentiation, maintaining a resting-like memory state by regulating IRF4 and IRF8 expression.

Owiredu et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark